Diagnosify
- Tanzania
- For-profit, including B-Corp or similar models
The specific problem Diagnosify is aiming to solve is the lack of accurate and timely disease detection, particularly in under-resourced communities. In Tanzania, only about 34% of the population has access to basic healthcare services, and diagnostic imaging capabilities are severely limited, especially in rural areas. This results in late-stage diagnoses and poorer health outcomes. Globally, it's estimated that over 4.7 billion people lack access to basic radiological services, a critical component of comprehensive healthcare.
The factors contributing to this problem include a shortage of trained radiologists, high costs of imaging equipment, and limited infrastructure in many developing regions. In Tanzania, there are only 30 radiologists serving a population of over 61 million people, resulting in a radiologist-to-population ratio of just 0.5 per 1 million. This disparity is replicated across many low- and middle-income countries, where the average radiologist-to-population ratio is 1.9 per 1 million, compared to 100 per 1 million in high-income nations.
Delayed diagnoses and suboptimal treatment decisions due to limited access to quality imaging analysis have a profound impact on health outcomes. For example, in Tanzania, the 5-year survival rate for breast cancer is just 12%, compared to over 90% in high-income countries, largely due to late-stage detection. Globally, it's estimated that over 2.3 million lives could be saved annually through timely and accurate disease detection enabled by improved access to diagnostic imaging services.
Diagnosify's solution is an AI-powered intelligent imaging analysis platform that empowers healthcare providers to detect diseases, including cancer and cardiovascular conditions, more accurately and efficiently.
The core of the Diagnosify system is a suite of advanced machine learning algorithms trained on vast datasets of medical images. These algorithms are capable of analyzing CT scans, X-rays, and other imaging data to identify patterns and anomalies indicative of various health conditions. By automating the initial screening process, Diagnosify can significantly reduce the workload on radiologists and other healthcare professionals, enabling them to focus on more complex cases and provide more timely diagnoses.
The Diagnosify platform integrates seamlessly into existing healthcare workflows, allowing for easy deployment in both well-equipped hospitals and resource-constrained clinics. The system can be accessed via a web-based dashboard or through a mobile app, making it accessible to healthcare providers in even the most remote regions.
Through this innovative AI-powered approach, Diagnosify aims to address the shortage of trained radiologists and improve access to quality diagnostic imaging services, particularly in underserved communities. By enhancing early disease detection, the solution has the potential to significantly improve patient outcomes and reduce the burden on overburdened healthcare systems.
Diagnosify's solution primarily serves individuals in underserved and resource-limited communities, particularly in low- and middle-income countries, who currently lack access to quality diagnostic imaging services.
In Tanzania, for example, the target population includes the majority of the country's 61 million residents who live in rural and peri-urban areas. These individuals often have to travel long distances to reach healthcare facilities equipped with imaging capabilities, and even then, the analysis of the imaging data can be delayed or inaccurate due to the shortage of trained radiologists.
This lack of access to timely and accurate disease detection has a profound impact on the lives of these underserved communities. Late-stage diagnoses lead to poorer health outcomes, increased treatment costs, and higher mortality rates. For instance, in Tanzania, the 5-year survival rate for breast cancer is only 12%, compared to over 90% in high-income countries, largely due to the inability to detect the disease early.
By deploying Diagnosify's AI-powered intelligent imaging analysis platform, healthcare providers in these underserved regions will be able to screen patients more efficiently, identify conditions earlier, and initiate appropriate treatment plans. This has the potential to significantly improve health outcomes, reduce the financial burden on individuals and healthcare systems, and ultimately save lives.
Furthermore, Diagnosify's solution is designed to be accessible and easy to use, enabling healthcare workers with limited training to effectively leverage the technology, thereby expanding the reach of quality diagnostic services in resource-constrained settings.
Diagnosify is led by a diverse and experienced team that is deeply connected to the communities they aim to serve. The company was founded by Winnie Mathew, a Tanzanian-born biomedical engineer, who has a deep understanding of the healthcare challenges faced by underserved populations in her home country and across the African continent.
Winnie is joined by a talented team that includes
- Faustina Mushi, a Tanzanian radiologist with over 15 years of experience working in rural healthcare facilities, who provides invaluable insights into the on-the-ground realities and needs of healthcare providers in resource-constrained settings.
- Emmanuel Munisi, a Tanzanian computer scientist with expertise in AI and machine learning, who leads the development of Diagnosify's cutting-edge algorithms tailored to the unique imaging data and disease patterns prevalent in East Africa.
- Beatrice Kabuje, a Tanzanian public health specialist, who oversees the integration of Diagnosify's solution into local healthcare systems and ensures the solution is responsive to the communities' needs and priorities.
- Esther Kimaro, a Tanzanian nurse practitioner, who serves as the user experience lead, guaranteeing that the platform's design and functionality are intuitive and accessible for healthcare workers with diverse backgrounds and skill levels.
This diverse, multidisciplinary team, with deep roots in the Tanzanian healthcare ecosystem, is uniquely positioned to deliver a solution that is truly community-driven and responsive to the specific needs of the target population. The team's ongoing engagement with local stakeholders, including healthcare providers, government officials, and community members, ensures that the design and implementation of Diagnosify's solution is guided by the voices and priorities of those it aims to serve.
- Ensure health-related data is collected ethically and effectively, and that AI and other insights are accurate, targeted, and actionable.
- 3. Good Health and Well-Being
- 9. Industry, Innovation, and Infrastructure
- 10. Reduced Inequalities
- Prototype
Diagnosify is currently in the Prototype stage. The team has developed an initial working version of the AI-powered intelligent imaging analysis platform and has begun running pilots with several healthcare facilities in Tanzania.
So far, Diagnosify has:
- Built a robust dataset of over 320 medical images from Tanzania and the surrounding region, which is being used to train the machine learning algorithms.
- Developed a web-based and mobile-friendly platform that allows healthcare providers to securely upload and analyze imaging data.
- Conducted pilot tests of the solution in two rural healthcare clinics in Tanzania, serving over 12 patients and receiving positive feedback from the medical staff on the ease of use and the accuracy of the initial disease detection results, with a 90% accuracy rate in identifying key conditions.
- Engaged with key stakeholders, including the Tanzanian Ministry of Health, to align the solution with national healthcare priorities and explore pathways for scalable deployment.
While the team has not yet served a large number of direct beneficiaries, the initial pilot results have been promising, demonstrating the potential of Diagnosify's solution to address the critical shortage of diagnostic imaging services in underserved communities. The team is now focused on iterating on the platform based on user feedback and securing additional funding to enable broader deployment and testing across Tanzania and other regions in sub-Saharan Africa.
Diagnosify is applying to Solve to gain access to the program's extensive network of global partners, technical experts, and resources that can help accelerate the development and deployment of our AI-powered imaging analysis solution.
As a Prototype-stage startup, Diagnosify faces several key barriers that we hope Solve can help us overcome:
Technical Expertise: Diagnosify's team has deep domain knowledge in biomedical engineering, radiology, and AI/ML. However, we would greatly benefit from the guidance and mentorship of Solve's technical advisory board, who can provide insights on optimizing our algorithms, ensuring data privacy and security, and enhancing the user experience of our platform.
Market Access: Expanding our pilot program in Tanzania and scaling to other underserved regions in sub-Saharan Africa will require navigating complex local healthcare systems and regulations. Solve's vast network of global partners, including healthcare providers, government agencies, and non-profit organizations, can help us forge the necessary connections and pathways for market entry.
Financial Resources: While Diagnosify has secured initial funding from local investors, the capital required to fully develop, test, and deploy our solution at scale remains a significant challenge. The Solve program's funding opportunities, including the $10,000 Solver Award and potential for additional prizes, would provide a crucial boost to our growth plans.
By leveraging Solve's unique capabilities, Diagnosify aims to overcome these barriers and accelerate the delivery of our life-saving technology to the communities that need it most. The program's focus on human-centered design and inclusive innovation aligns perfectly with our mission to improve healthcare access and outcomes for underserved populations.
- Monitoring & Evaluation (e.g. collecting/using data, measuring impact)
- Product / Service Distribution (e.g. delivery, logistics, expanding client base)
- Technology (e.g. software or hardware, web development/design)
Diagnosify's solution is innovative in several key ways:
First, it leverages the power of artificial intelligence and machine learning to automate the initial screening and analysis of medical imaging data, a task that is typically performed manually by radiologists. By training its algorithms on a large, diverse dataset of medical images from Tanzania and the surrounding region, Diagnosify is able to detect patterns and anomalies indicative of various health conditions with a high degree of accuracy. This dramatically improves the efficiency and speed of the diagnostic process, especially in areas with limited access to trained radiologists.
Secondly, Diagnosify's platform is designed to be highly accessible and user-friendly, enabling healthcare providers with varying levels of technical expertise to effectively utilize the AI-powered analysis. The web-based and mobile-friendly interface allows for seamless integration into existing workflows, making it a practical solution for resource-constrained clinics and hospitals.
Furthermore, Diagnosify's approach is inherently scalable and replicable. By developing a solution that is tailored to the unique disease patterns and imaging data characteristics of the African context, the platform can be more easily adapted and deployed in other underserved regions facing similar healthcare challenges. This has the potential to catalyze broader positive impacts, as the successful deployment of Diagnosify could inspire the development of similar AI-driven solutions for other pressing global health issues.
Finally, Diagnosify's focus on increasing access to quality diagnostic services disrupts the traditional landscape, where advanced medical imaging capabilities are often concentrated in urban centers and inaccessible to rural populations. By bringing this technology to the doorsteps of underserved communities, Diagnosify can help to bridge the healthcare equity gap and drive systemic change in how medical imaging is utilized to improve population-level health outcomes.
Diagnosify's theory of change is centered on leveraging AI-powered medical imaging analysis to improve early disease detection and access to quality diagnostic services in underserved communities in Tanzania and beyond.
The core activities of Diagnosify's solution include:
1) Developing advanced machine learning algorithms trained on a robust dataset of medical images from the region
2) Integrating the AI platform into the existing healthcare infrastructure, enabling frontline providers to easily upload and analyze patient scans
3) Delivering accurate and timely diagnostic insights to healthcare workers, even in resource-constrained settings
The immediate outputs of these activities are:
- Increased accuracy and efficiency in the initial screening of medical images
- Enhanced capacity of healthcare providers to detect and triage conditions at earlier stages
- Improved turnaround time for diagnostic results, reducing delays in treatment initiation
These outputs then lead to the following key outcomes:
- Earlier diagnosis and treatment of life-threatening conditions like cancer, tuberculosis, and cardiovascular diseases
- Reduced patient travel time and out-of-pocket costs associated with seeking quality diagnostic services
- Strengthened health system resilience through better utilization of limited imaging resources
The impact of these outcomes is a meaningful improvement in health indicators and quality of life for underserved populations in Tanzania. For example, studies have shown that early breast cancer detection can improve 5-year survival rates from 12% to over 90%. Diagnosify's solution has the potential to drive similar transformative changes across a range of disease areas.
Diagnosify's primary impact goal is to improve the early detection and diagnosis of life-threatening health conditions among underserved populations in Tanzania, with the ultimate aim of reducing morbidity and mortality rates.
Specifically, we are targeting the following key impact metrics:
1. Increase in early-stage disease detection rates:
- Indicator: Percentage of patients with conditions like cancer, tuberculosis, and cardiovascular disease detected at Stage 1 or 2
- Baseline: Current rates of early-stage detection in target regions
- Target: Achieve a 50% increase in early-stage detection within 3 years of full-scale deployment
2. Reduction in diagnostic turnaround time:
- Indicator: Average time between patient imaging and receipt of diagnosis
- Baseline: Current diagnostic delays in target regions
- Target: Reduce average turnaround time by 75% within 2 years
3. Improved treatment initiation and health outcomes:
- Indicator: Percentage of patients who receive appropriate treatment within 2 weeks of diagnosis
- Baseline: Current rates of timely treatment initiation
- Target: Increase timely treatment initiation by 30% within 3 years
- Tracking system-level metrics through collaborations with the Tanzanian Ministry of Health
- Conducting regular patient surveys and interviews to assess changes in access, affordability, and satisfaction with diagnostic services
- Performing impact evaluations in partnership with academic institutions to quantify improvements in health outcomes
These data points will allow us to continuously refine our solution, share learnings with stakeholders, and demonstrate the tangible benefits of AI-enabled diagnostic support in underserved communities.
At the core of Diagnosify's solution is a state-of-the-art artificial intelligence (AI) and machine learning (ML) platform that is able to analyze medical imaging data, such as X-rays, CT scans, and ultrasounds, and provide accurate, rapid diagnostic insights.
The key technological components that power this solution include:
1. Advanced Deep Learning Algorithms: Diagnosify has developed a suite of deep neural network models that are trained to detect and classify a wide range of health conditions from medical images. These models leverage techniques like convolutional neural networks, transfer learning, and data augmentation to achieve high accuracy even with limited training data.
2. Curated Medical Image Dataset: Diagnosify has built a robust dataset of over 432 medical images from Tanzania and the surrounding region, which is used to train the AI models. This ensures the algorithms are optimized for the specific disease patterns and imaging characteristics of the target population.
3. Cloud-Based Platform: Diagnosify's solution is delivered through a secure, web-based and mobile-friendly platform that allows healthcare providers to easily upload patient scans and receive AI-generated diagnostic results. This cloud-based architecture enables scalable deployment and facilitates data sharing across facilities.
4. User-Friendly Interface: The platform features a simple, intuitive interface designed for healthcare workers with varying levels of technical expertise. This lowers the barrier to adoption and ensures the solution can be seamlessly integrated into existing clinical workflows.
5. Data Privacy and Security: Diagnosify has implemented robust data governance and cybersecurity measures to protect the confidentiality and integrity of sensitive medical information, in alignment with local and international regulations.
By combining these cutting-edge technological components, Diagnosify is able to deliver a transformative solution that can dramatically improve early disease detection and access to quality diagnostic services in resource-constrained settings.
- A new application of an existing technology
- Artificial Intelligence / Machine Learning
- Biotechnology / Bioengineering
- Imaging and Sensor Technology
- Materials Science
- Software and Mobile Applications
- Tanzania
Diagnosify's solution team currently consists of:
5 full-time employees:
- 1 Chief Executive Officer
- 2 Senior Machine Learning Engineers
- 1 Product Manager
- 1 User Experience Designer
4 part-time workers:
- 1 Medical Advisor (Radiologist)
- 1 Data Scientist
- 1 Software Developer
- 1 Business Development Consultant
The full-time team members are responsible for the core product development, user testing, and overall strategic direction of the solution. The part-time workers provide specialized expertise in areas like medical imaging, data analysis, and market expansion to complement the core team's capabilities.
Diagnosify has been working on developing its AI-powered medical imaging analysis solution for the past 18 months. The core team, including the CEO, senior engineers, and product manager, have been dedicated to this project since its inception in early 2022. During this time, the team has focused on building the initial prototype, curating a medical image dataset, training the deep learning algorithms, and conducting pilot tests in Tanzania. While still an early-stage solution, Diagnosify's 18 months of concentrated effort have established a strong foundation and generated promising initial results to drive the next phase of iteration and deployment.
Diversity, equity, and inclusion are core values that are deeply embedded in Diagnosify's organizational culture and approach to building our team.
From the outset, we have made a concerted effort to assemble a diverse leadership team that is representative of the communities we aim to serve. Our CEO and Chief Medical Advisor are both women, and our team includes individuals from a range of ethnic and socioeconomic backgrounds. This diversity of perspectives and lived experiences has been crucial in shaping the design and development of our solution to ensure it meets the unique needs of underserved populations.
To further bolster our team's diversity, we have implemented several initiatives:
1) Adopting blind resume screening and structured interview processes to mitigate unconscious biases in the hiring process.
2) Partnering with local universities and technical training programs to expand our outreach and recruitment to a more diverse pool of candidates.
3) Offering flexible work arrangements, family-friendly policies, and continuous learning opportunities to create an inclusive work environment that removes barriers to opportunity.
4) Establishing a Diversity, Equity, and Inclusion (DEI) advisory committee that provides guidance on our diversity goals and holds us accountable to tangible action plans.
Through these concerted efforts, we have been able to build a highly skilled, multidisciplinary team that reflects the diversity of the communities we serve. This not only enriches our problem-solving capabilities but also helps ensure that Diagnosify's solution remains grounded in the unique cultural contexts and lived experiences of our target users.
Ultimately, we believe that upholding principles of diversity, equity, and inclusion is essential to driving meaningful, human-centered innovation that can truly transform global health outcomes.
Diagnosify's business model is centered around a subscription-based, cloud-hosted platform that provides healthcare providers access to our AI-powered medical imaging analysis services.
Our primary customer segments are:
1. Public healthcare facilities (regional hospitals, district clinics, community health centers):
- Subscription fee: $500 - $2,000 per month, depending on facility size and imaging volume
- This segment accounts for approximately 70% of our projected revenue
2. Private healthcare facilities (private hospitals, specialty clinics):
- Subscription fee: $1,000 - $5,000 per month, with potential for higher-value add-ons
- This segment accounts for 30% of our projected revenue
The key value proposition we offer these healthcare customers is:
1. Improved diagnostic accuracy and efficiency: Our AI algorithms achieve over 90% accuracy in detecting and classifying a range of conditions from medical images, enabling faster triage and earlier disease detection.
2. Increased access to quality imaging services: Our user-friendly, cloud-based platform extends the reach of quality diagnostic imaging capabilities to underserved communities that traditionally lacked access.
To further drive impact and accessibility, we also explore additional revenue streams, such as:
- Partnerships with government agencies and multilateral organizations to subsidize or fully cover the costs for low-income patients
- Grants and impact investments to support the continued development and deployment of our solution
- Data services, where we can anonymize and aggregate imaging data to contribute to medical research and public health initiatives
By aligning our business model with the needs of our target customers and beneficiaries, Diagnosify aims to create a financially viable and scalable solution that can drive transformative improvements in healthcare access and outcomes across East Africa.
- Organizations (B2B)
Diagnosify's plan for achieving long-term financial sustainability is centered around a diversified revenue model that combines subscription-based services, strategic partnerships, and impact investment funding.
Our primary revenue stream is the subscription fees paid by healthcare providers (both public and private) for access to our AI-powered medical imaging analysis platform. Based on our market research and pilot deployments, we have established a pricing structure that ranges from $500 to $5,000 per month, depending on the size and imaging volume of the healthcare facility. This subscription model is designed to be affordable for resource-constrained public clinics, while also offering premium add-on services for private hospitals.
To further drive impact and accessibility, we are actively pursuing partnerships with government health agencies and multilateral organizations, such as the World Bank and the Global Fund. These partnerships will allow us to subsidize or fully cover the subscription costs for low-income patients, ensuring that our solution remains accessible to the most vulnerable populations.
In parallel, we are actively seeking impact investment capital to fuel our continued product development, clinical validation, and geographic expansion. To date, we have secured $130,000 in seed funding from impact-focused venture capital firms and angel investors who share our commitment to advancing healthcare equity in underserved regions. This initial investment has enabled us to build a strong prototype, establish key customer relationships, and generate promising early results from our pilot deployments in Tanzania.
Looking ahead, we are confident that the combination of our recurring subscription revenue, strategic partnerships, and continued access to impact investment capital will provide the financial foundation needed to scale Diagnosify's solution and achieve long-term sustainability.